Table 1.
Ref.
|
Year
|
Study type
|
No of patients
|
GI etiology
|
No of males/females
|
Age
|
Study period
|
Bager et al[5] | 2013 | Retrospective | 169 | Nonvariceal AUGIB | 86/83 | 70 (22-95)1 | 2009 |
Bager et al[44] | 2014 | Double-blind, randomized, placebo-control | 97 | Nonvariceal AUGIB | 51/46 | 70 (23-95)2 | 2010-2013 |
Bager et al[50] | 2014 | Double-blind, randomized, placebo-control | 97 | Nonvariceal AUGIB | 51/46 | 70 (67.4-73.1)3 | - |
Ballester et al[45] | 2019 | Retrospective, single-center | 84 | Acute GIB | 58/26 | 68.0 (16.9)2 | 2012-2015 |
Bosch et al[51] | 2017 | Prospective cohort | 2818 | GI diseases known to cause GIB | 1398/1420 | 63.4 (15.7)2 | 2015-2016 |
Bosch et al[29] | 2017 | Prospective cohort | 4552 | Occult bleeding | 2266/2286 | 63.7 (17.6)2 | 2005-2015 |
Brooklyn et al[6] | 2003 | N/A | 153 | Occult bleeding | 51/102 | 66 (45-96)2 | 2000 |
Cheng et al[52] | 2010 | Prospective | 390 | Ulcers | 263/127 | 63 (16)2 | - |
El-Halabi et al[7] | 2016 | Retrospective, chart review, single-center | 307 | Any GIB | 130/177 | 66.2 (18.6)2 | 2011-2012 |
Geisser et al[46] | 2010 | Phase I/II, multicenter, open-label, multiple-dose | 46 | Bleeding due to GI disorder | 10/36 | 42.9 (11.0)2 | 2003-2004 |
Jairath et al[35] | 2010 | Meta-analysis | - | AUGIB | 2731/1710 | Early RBC 67.9 (16.51)2; no early RBC 63.4 (19.19)2 | 2007 |
Jairath et al[36] | 2015 | Pragmatic, multicentric, open-label, randomized feasibility trial | 936 | AUGIB | 566/370 | Liberal 60.4 (20.0)2; restrictive 58.0 (20.3)2 | 2012-2013 |
Restellini et al[31] | 2013 | Observational, registry-based | 1677 | Nonvariceal AUGIB | 1035/642 | 66.2 (16.8)2 | 1999-2002 |
Rockey et al[32] | 2017 | Prospective cohort | 1460 | Acute or chronic GIB | 899/561 | 53 (14)2 | 2006-2011 |
Salvadori et al[47] | 2016 | Retrospective | 38 | GI chronic blood loss | 22/16 | 78 (54-94)4 | 2014-2015 |
Schröder et al[48] | 2004 | N/A | 31 | GI blood loss | 12/19 | 43.8 (18.0)2 | - |
Subramaniam et al[30] | 2016 | Retrospective cohort | 2360 | Nonvariceal AUGIB | 1505/852 | 70 (56-81)4 | 2008-2010 |
Villanueva et al[37] | 2013 | RCT | 889 | Severe AUGIB | - | - | 2003-2009 |
The median (range).
The mean (range) or mean (standard deviation).
Mean (95% confidence interval).
The median (Interquartile range). AUGIB: Acute upper gastrointestinal bleeding; GI: Gastrointestinal; GIB: Gastrointestinal bleeding; RBC: Red blood cell; RCT: Randomized controlled trial.